{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:14:43Z","timestamp":1789384483539,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1002\/jps.22583","type":"journal-article","created":{"date-parts":[[2011,4,25]],"date-time":"2011-04-25T21:29:29Z","timestamp":1303766969000},"page":"3332-3344","source":"Crossref","is-referenced-by-count":39,"title":["Manufacture and Performance Evaluation of a Stable Amorphous Complex of an Acidic Drug Molecule and Neusilin"],"prefix":"10.1016","volume":"100","author":[{"given":"Jenifer","family":"Maclean","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominick","family":"Daurio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Alvarez\u2010Nunez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janan","family":"Jona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Munson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthik","family":"Nagapudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1002\/jps.22583_bb0010","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1021\/mp800061r","article-title":"Enhanced bioavailability of a poorly soluble VR1 antagonist using an amorphous solid dispersion approach: A case study","volume":"5","author":"Kennedy","year":"2008","journal-title":"Mol Pharm"},{"issue":"1","key":"10.1002\/jps.22583_bb0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0169-409X(01)00098-9","article-title":"Amorphous pharmaceutical solids: Preparation, characterization and stabilization","volume":"48","author":"Yu","year":"2001","journal-title":"Adv Drug Delivery Rev"},{"issue":"10","key":"10.1002\/jps.22583_bb0020","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1021\/js980403l","article-title":"Solid dispersion of poorly water\u2010soluble drugs: Early promises, subsequent problems, and recent breakthroughs","volume":"88","author":"Serajuddin","year":"1999","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1002\/jps.22583_bb0025","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/(SICI)1520-6017(200001)89:1<128::AID-JPS13>3.0.CO;2-Z","article-title":"Physical characteristics and chemical degradation of amorphous quinapril hydrochloride","volume":"89","author":"Guo","year":"2000","journal-title":"J Pharm Sci"},{"issue":"11","key":"10.1002\/jps.22583_bb0030","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1002\/jps.20182","article-title":"Ability of polyvinylpyrrolidone and polyacrylic acid to inhibit the crystallization of amorphous acetaminophen","volume":"93","author":"Miyazaki","year":"2004","journal-title":"J Pharm Sci"},{"issue":"3","key":"10.1002\/jps.22583_bb0035","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.ejpb.2008.02.007","article-title":"Characterization of ternary solid dispersions of Itraconazole in polyethylene glycol 6000\/polyvidone\u2010vinylacetate 64 blends","volume":"69","author":"Janssens","year":"2008","journal-title":"Eur J Pharm Biopharm"},{"issue":"2","key":"10.1002\/jps.22583_bb0040","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ejpb.2008.05.023","article-title":"Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine","volume":"70","author":"Konno","year":"2008","journal-title":"Eur J Pharm Biopharm"},{"issue":"5","key":"10.1002\/jps.22583_bb0045","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s11095-010-0069-y","article-title":"Influence of preparation methods on solid state supersaturation of amorphous solid dispersions: A case study with Itraconazole and Eudragit E100","volume":"27","author":"Janssens","year":"1996","journal-title":"Pharm Res"},{"issue":"5","key":"10.1002\/jps.22583_bb0050","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1021\/mp900050c","article-title":"Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture","volume":"6","author":"Rumondor","year":"2009","journal-title":"Mol Pharm"},{"issue":"3","key":"10.1002\/jps.22583_bb0055","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/jps.10566","article-title":"Ritonavir\u2010PEG 8000 amorphous solid dispersions: In vitro and in vivo evaluations","volume":"93","author":"Law","year":"2004","journal-title":"J Pharm Sci"},{"issue":"3","key":"10.1002\/jps.22583_bb0060","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/jps.10308","article-title":"Formation of physically stable amorphous drugs by milling with neusilin","volume":"92","author":"Gupta","year":"2003","journal-title":"J Pharm Sci"},{"issue":"10","key":"10.1002\/jps.22583_bb0065","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1007\/s11095-006-9062-x","article-title":"Amorphization of indomethacin by co\u2010grinding with Neusilin US2: Amorphization kinetics, physical stability and mechanism","volume":"23","author":"Bahl","year":"2006","journal-title":"Pharm Res"},{"issue":"1\u20132","key":"10.1002\/jps.22583_bb0070","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0378-5173(01)00776-1","article-title":"Stability of amorphous indomethacin compounded with silica","volume":"226","author":"Watanabe","year":"2001","journal-title":"Int J Pharm"},{"issue":"1\u20132","key":"10.1002\/jps.22583_bb0075","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0378-5173(02)00428-3","article-title":"Prediction of apparent equilibrium solubility of indomethacin compounded with silica by 13C solid statenmR","volume":"248","author":"Watanabe","year":"2002","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1002\/jps.22583_bb0080","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/jps.10026","article-title":"Improvement of solubility and oral bioavailability of a poorly water\u2010soluble drug, TAS\u2010301, by its melt\u2010adsorption on a porous calcium silicate","volume":"91","author":"Kinoshita","year":"2002","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1002\/jps.22583_bb0085","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ejpb.2007.06.003","article-title":"Formation of physically stable amorphous phase of ibuprofen by solid state milling with kaolin","volume":"68","author":"Mallick","year":"2008","journal-title":"Eur J Pharm Biopharm"},{"issue":"2","key":"10.1002\/jps.22583_bb0090","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1021\/js9601748","article-title":"Polymorphism of Sulindac: Isolation and characterization of a new polymorph and three new solvates","volume":"86","author":"Tros deIlarduya","year":"1997","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.22583_bb0095","series-title":"Transformation of pharmaceutical compounds by mechanical activation. Solid\u2010Solid Phase Transformations in Inorganic Materials, Proceeding of the International Conference","first-page":"835","author":"Descamps","year":"2005"},{"issue":"5","key":"10.1002\/jps.22583_bb0100","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/jps.20939","article-title":"Transformation of pharmaceutical compounds upon milling and comilling: The role of Tg","volume":"96","author":"Descamps","year":"2007","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1002\/jps.22583_bb0105","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/jps.10028","article-title":"Cryogenic grinding of indomethacin polymorphs and solvates: Assessment of amorphous phase formation and amorphous phase physical stability","volume":"91","author":"Crowley","year":"2002","journal-title":"J Pharm Sci"},{"issue":"4","key":"10.1002\/jps.22583_bb0110","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1248\/cpb.34.1784","article-title":"Effect of environmental temperature on polymorphic solid\u2010state transformation of indomethacin during grinding","volume":"34","author":"Otsuka","year":"1986","journal-title":"Chem Pharm Bull"},{"issue":"16","key":"10.1002\/jps.22583_bb0115","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1139\/v78-348","article-title":"Carbon\u201013 nuclear magnetic resonance studies of (Z)\u20105\u2010fluoro\u20102\u2010methyl\u20101\u2010{[p\u2010(methylsulfinyl)phenyl]methylene}\u20101H\u2010indene\u20103\u2010acetic acid (sulindac) and some related compounds","volume":"56","author":"Douglas","year":"1978","journal-title":"Can J Chem"},{"issue":"1","key":"10.1002\/jps.22583_bb0120","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1006\/jssc.2001.9436","article-title":"Solid state radical recombination and charge transfer across the boundary between indomethacin and silica under mechanical stress","volume":"164","author":"Watanabe","year":"2002","journal-title":"J Solid State Chem"},{"issue":"2","key":"10.1002\/jps.22583_bb0125","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1208\/s12249-009-9221-6","article-title":"Preparation and characterization of co\u2010grinded mixtures of aceclofenac and neusilin US2 for dissolution enhancement of aceclofenac","volume":"10","author":"Vadher Ambarish","year":"2009","journal-title":"AAPS Pharm Sci Tech"},{"issue":"1","key":"10.1002\/jps.22583_bb0130","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1208\/s12249-007-9013-9","article-title":"Amorphization alone does not account for the enhancement of solubility of drug co\u2010ground with silicate: The case of indomethacin","volume":"9","author":"Bahl","year":"2008","journal-title":"AAPS Pharm Sci Tech"},{"issue":"2","key":"10.1002\/jps.22583_bb0135","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1107\/S0021889807007832","article-title":"A new method for the reproducible generation of polymorphs: Two forms of sulindac with very different solubilities","volume":"40","author":"Llinas","year":"2007","journal-title":"J Appl Crystallogr"},{"issue":"2","key":"10.1002\/jps.22583_bb0140","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/jps.21451","article-title":"Characterization and optimization of AMG 517 supersaturatable self\u2010emulsifying drug delivery system (S\u2010SEDDS) for improved oral absorption","volume":"98","author":"Gao","year":"2009","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1002\/jps.22583_bb0145","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1081\/DDC-120028718","article-title":"Enhanced oral bioavailability of a poorly water soluble drug PNU\u201091325 by supersaturatable formulations","volume":"30","author":"Gao","year":"2004","journal-title":"Drug Dev Ind Pharm"},{"issue":"12","key":"10.1002\/jps.22583_bb0150","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1002\/jps.10511","article-title":"Development of a supersaturable SEDDS (S\u2010SEDDS) formulation of paclitaxel with improved oral bioavailability","volume":"92","author":"Gao","year":"2003","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1002\/jps.22583_bb0155","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1166\/jbn.2007.001","article-title":"Dissolution rates and supersaturation behavior of amorphous repaglinide particles produced by controlled precipitation","volume":"3","author":"Sinswat","year":"2007","journal-title":"J Biomed Nanotechnol"},{"issue":"4","key":"10.1002\/jps.22583_bb0160","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2174\/157340708786847852","article-title":"Amorphous active pharmaceutical ingredients in preclinical studies: Preparation, characterization, and formulation","volume":"4","author":"Nagapudi","year":"2008","journal-title":"Curr Bioact Compd"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915320281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915320281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T05:21:24Z","timestamp":1543814484000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354915320281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0022354915320281"],"URL":"https:\/\/doi.org\/10.1002\/jps.22583","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}